Table 1.
TB Infection and COVID-19 | Immune Response | First Author, Year of Publication |
---|---|---|
LTBI + COVID-19 (clinical case) | decline in CD4+ T cell count along with latent-to-active TB progression | Khayat M, 2021 [24] |
LTBI + COVID-19 (study data) | LTBI with COVID-19 showed significantly higher plasma levels of IFN γ, IL-2, TNF α, IL- 1 α, IL-1 β, IL-6, IL-12, IL-15, IL-17, IL-3, GM-CSF, IL-10, IL-25, IL-33, CCL3 and CXCL10 | Rajamanickam A, 2021 [25] |
LTBI + COVID-19 (review) | decreased cytokine levels shown for IL-2, IL-4, IL-5 and IL-13 | Shariq M, 2022 [26] |
LTBI + COVID-19 (study data) |
LTBI in COVID subjects had lowered CD8+ T cell count and IFN-γ level | Palacios-Gutiérrez JJ, 2022 [27] |
TB +COVID-19 (study data) |
low level of IFN-γ in COVID-19 and TB patients | Petrone L, 2021 [28] |
TB +COVID-19 (study data) |
decreased SARS-CoV-2-specific CD4 T cell level in COVID-19 and TB patients | Flores-Lovon K, 2022 [29] |